Completion axillary lymph node dissection (CALND) is controversial in patients with sentinel lymph node (SLN) metastases ? 0.2 mm [N0(i+)]. Our goal was to characterize patients with SLN isolated tumor cells regarding surgical management and axillary recurrence.